We are live on ! Find out more
GF

Gates Foundation Portfolio holdings

AUM $43.5M
1-Year Est. Return 14.19%
This Fund
S&P 500
This Quarter Est. Return
+34.88%
1 Year Est. Return
+14.19%
3 Year Est. Return
-58.08%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$611M
AUM Growth
+$173M
Cap. Flow
+$45.7M
Cap. Flow %
7.48%
Top 10 Hldgs %
100%
Holding
7
New
2
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
IMCR icon
Immunocore
IMCR
+$25.7M
2
BFLY icon
Butterfly Network
BFLY
+$20M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 99.09%
2 Materials 0.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CVAC
1
DELISTED
CureVac
CVAC
$287M 46.92%
3,134,780
– –
VIR icon
2
Vir Biotechnology
VIR
$1.49B
$142M 23.3%
2,777,777
– –
BNTX icon
3
BioNTech
BNTX
$22.8B
$113M 18.56%
1,038,674
– –
IMCR icon
4
Immunocore
IMCR
$1.78B
$24.6M 4.02%
+576,923
New +$25.7M
BCEL
5
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
$21.4M 3.5%
1,396,644
– –
BFLY icon
6
Butterfly Network
BFLY
$1.74B
$17M 2.78%
+1,011,003
New +$20M
AMRS
7
DELISTED
Amyris Inc.
AMRS
$5.58M 0.91%
292,398
– –

Similar funds

NV
Northpond Ventures Bethesda, Maryland $43.7M AUM 27.27% 1-Year Est. Return
IV
Industry Ventures San Francisco, California $43.2M AUM 36.57% 1-Year Est. Return
RCM
Riverwood Capital Management Menlo Park, California $43.2M AUM 24% 1-Year Est. Return
EPWM
Essex Private Wealth Management Topsfield, Massachusetts $42.5M AUM 29.61% 1-Year Est. Return
SCMC
Serent Capital Management Company San Francisco, California $44.9M AUM 20.57% 1-Year Est. Return
GF
Genesis Fortune Grand Cayman, Cayman Islands $41.8M AUM 76.19% 1-Year Est. Return
AS
AM Squared Hong Kong $45.2M AUM 4.27% 1-Year Est. Return
BCP
Berylson Capital Partners Boston, Massachusetts $41.2M AUM 0.19% 1-Year Est. Return

Gates Foundation's Q1 2021 Portfolio in Review

As of Q1 2021, Gates Foundation held 7 positions worth $611M, up 40% from $438M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Gates Foundation deployed $45.7M of net new capital in Q1 2021, opening 2 new positions. Its largest new stake was Immunocore: 576,923 shares worth $24.6M.

By sector, the portfolio is most concentrated in Healthcare at 99% of assets, down from 100% a quarter earlier, followed by Materials.

  • Gates Foundation's largest Q1 2021 buy was Immunocore: 576,923 shares worth $24.6M.
  • Gates Foundation's ten largest holdings make up 100% of its $611M portfolio in Q1 2021.
  • Gates Foundation opened 2 new positions and closed 0 in Q1 2021.
  • Gates Foundation's portfolio value rose 40% quarter-over-quarter to $611M.

Based on Gates Foundation's 13F filing for Q1 2021, filed 14 May 2021.